Prof. Dr. LEYLA OZER

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , cilt.35, sa.7, ss.6941-8, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Coagulation tests show significant differences in patients with breast cancer

TAŞ F., Kilic L., DURANYILDIZ H. D.

TUMOR BIOLOGY , cilt.35, sa.6, ss.5985-5992, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Intolerance to sunitinib treatment in hemodialysis patients with metastatic renal cell carcinoma.

YILDIZ İ., Sen F., Kilic L., Ciftci R., BAŞARAN M.

Korean journal of urology , cilt.55, sa.1, ss.74-6, 2014 (Hakemli Dergi)

33. Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-up

ELİTOK A., Oz F., Cizgici A. Y., Kilic L., Ciftci R., Sen F., et al.

CARDIOLOGY JOURNAL , cilt.21, sa.5, ss.509-515, 2014 (SCI-Expanded)

34. Aspirin resistance in patients with impaired renal functions

Aksu H. U., Oner E., Erturk M., Aksu H., Isiksacan N., Ozalp B., et al.

KARDIOLOGIA POLSKA , cilt.72, sa.4, ss.331-338, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Age is a prognostic factor affecting survival in lung cancer patients

TAŞ F., Ciftci R., Kilic L., KARABULUT S.

ONCOLOGY LETTERS , cilt.6, sa.5, ss.1507-1513, 2013 (SCI-Expanded, Scopus)

36. Performance status of patients is the major prognostic factor at all stages of pancreatic cancer.

TAŞ F., Sen F., Odabas H., Kilic L., Keskin S., YILDIZ İ.

International journal of clinical oncology , cilt.18, sa.5, ss.839-46, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. Serum M65 as a biomarker for metastatic renal cell carcinoma.

YILDIZ İ., Sen F., Kilic L., Keskin S., DURANYILDIZ H. D., Bilgin E., et al.

Clinical genitourinary cancer , cilt.11, sa.3, ss.290-6, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. Clinical and prognostic significance of coagulation assays in gastric cancer

TAŞ F., Ciftci R., Kilic L., SERİLMEZ M., KARABULUT S., Duranyildiz D.

Journal of Gastrointestinal Cancer , cilt.44, sa.3, ss.285-292, 2013 (Scopus) Sürdürülebilir Kalkınma

39. A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer

Yildiz İ., Tas F., Kilic L., Sen F., Saip P., Eralp Y., et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , cilt.72, sa.2, ss.437-444, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival.

TAŞ F., Sen F., Keskin S., Kilic L., YILDIZ İ.

Molecular and clinical oncology , cilt.1, sa.4, ss.788-792, 2013 (Hakemli Dergi) Sürdürülebilir Kalkınma

41. Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib.

Sen F., Yildiz İ., Başaran M., Ekenel M., Oz F., Kilic L., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.18, sa.3, ss.775-81, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi's sarcoma (CKS): a single-arm trial (oral etoposide in CKS)

TAŞ F., AYDOĞMUŞ ŞEN F., Keskin S., Kilic L.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.27, sa.6, ss.789-792, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC).

Keskin S., YILDIZ İ., AYDOĞMUŞ ŞEN F., AYDOĞAN F., Kilic L., EKENEL M., et al.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico , cilt.15, sa.5, ss.403-8, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. Clinical and prognostic significance of coagulation assays in lung cancer

TAŞ F., Kilic L., SERİLMEZ M., Keskin S., Sen F., DURANYILDIZ H. D.

RESPIRATORY MEDICINE , cilt.107, sa.3, ss.451-457, 2013 (SCI-Expanded, Scopus)

45. Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients.

Aydiner A., Kilic L., Yildiz İ., Keskin S., Sen F., Kucucuk S., et al.

Medical oncology (Northwood, London, England) , cilt.30, sa.1, ss.354, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer.

TAŞ F., Kilic L., Bilgin E., Keskin S., Sen F., Ciftci R., et al.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society , cilt.23, sa.2, ss.276-81, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy.

Aykan N. F., Yildiz İ., Sen F., Kilic L., Keskin S., Ciftci R., et al.

Medical oncology (Northwood, London, England) , cilt.30, sa.3, ss.679, 2013 (SCI-Expanded, Scopus)

48. Does Beta-blocker Therapy Improve the Survival of Patients with Metastatic Non-small Cell Lung Cancer?

AYDINER A., Ciftci R., KARABULUT S., Kilic L.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.10, ss.6109-6114, 2013 (SCI-Expanded, Scopus)

49. Clinical significance of coagulation assays in metastatic pancreatic adenocarcinoma

TAŞ F., KARABULUT S., Bilgin E., Kılıc L., Ciftci R., Duranyildiz D.

Journal of Gastrointestinal Cancer , cilt.44, sa.4, ss.404-409, 2013 (Scopus)

50. Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?

Kilic L., Ordu C., EKENEL M., YILDIZ İ., Keskin S., Sen F., et al.

Medical oncology (Northwood, London, England) , cilt.30, sa.3, ss.660, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. Clinical and prognostic significance of coagulation assays in melanoma.

TAŞ F., Ciftci R., Kilic L., Bilgin E., Keskin S., Sen F., et al.

Melanoma research , cilt.22, sa.5, ss.368-75, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels

ŞANLI Y., KUYUMCU S., ÖZKAN Z. G., Kilic L., Balik E., TÜRKMEN C., et al.

ANNALS OF NUCLEAR MEDICINE , cilt.26, sa.7, ss.551-558, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.

TAŞ F., Keskin S., Karadeniz A., Dagoglu N., Sen F., Kilic L., et al.

Oncology , cilt.81, sa.5-6, ss.353-8, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. Optic disc and choroidal metastasis from sporadic medullary thyroid carcinoma: case report and review of the literature.

Yildiz İ., Sen F., Tuncer S., Kilic L., Basaran M., Bavbek S.

Onkologie , cilt.34, sa.11, ss.630-3, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 14

1. Karaciğer Metastazı Olan Evre IV Kolorektal Kanser Hastalarının Küratif Tedavisinin Planlanmasında Multidisipliner Tümör Konseyi Kararlarının Etkisi

Cakcak İ. E., Aytaç E., Özben V., Özer L., Yıldız İ., Gönenç M., et al.

22. Ulusal Cerrahi Kongresi, Antalya, Türkiye, 23 - 27 Mart 2022, ss.10, (Özet Bildiri)

2. Positive MRI findings in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy

Erdemli S., Taşkın F., Erdoğdu İ. H., Tokat F., Behzatoğlu K., Meydan N., et al.

European Congress of Radiology, Vienna, Avusturya, 3 - 07 Mart 2021, ss.164-165, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Clinicopathological and prognostic significance of microsatellit instability (MSI) status and PDI-1 expression in Turkish patients with gastric cancer.

Yildiz İ., Bahsi S., Erdamar S., Goksel S., Demir G., Er Ö., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Factors affecting progression free survival in non-HIV related classical Kaposi sarcoma.

Sen F., Tambas M., Ciftci R., Toz B., Kilic L., Bozbey H. U., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)

5. Distribution and frequency of BRCA gene mutations in Turkish population including Balkan Turks

Akdeniz D., Tuncer B. S., Kilic S., Sukruoglu O., Kilic L., Altundag K., et al.

AACR Special Conference on Cancer Susceptibility and Cancer Susceptibility Syndromes, California, Amerika Birleşik Devletleri, 29 Ocak - 01 Şubat 2014, cilt.74, (Özet Bildiri)

6. Serum inflammatory parameters as prognostic factors in patients with gastic cancer: Is serum albumin the best inflammotory biomarker predicting prognosis?

Sen F., Zobaci E., Erdemli H. K., Kocabas R., Kilic L., Ylidiz I.

50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)

7. Clinical and pathologic characteristics of ovarian cancer patients with BRCA1 and BRCA2 mutations in Turkish population

SAİP P. M., Akdeniz B., Tuncer B., Kilic S., Sukruoglu O., Altundag K., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)

8. Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.

Ciftci R., TAŞ F., Aksit E., VATANSEVER S., KARABULUT S., Sen F., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma

9. Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma

KARABULUT S., Aykan N. F., Yildiz İ., Kilic L., Sen F., VATANSEVER S.

Gastrointestinal Cancers Symposium, San-Francisco, Kostarika, 16 - 18 Ocak 2014, cilt.32, (Özet Bildiri)

10. Comparison of mucosal and cutaneous melanoma in the head and neck region: Different clinical features and similar outcomes.

Ciftci R., Keskin S., KARABULUT S., Yildiz İ., Kilic L., Sen F., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

11. Is there any prognostic importance of pretreatment serum M30 and serum M65 levels on progression-free survival of patients with metastatic renal cell carcinoma treated with first-line sunitinib?

BAŞARAN M., Yildiz İ., Sen F., Kilic L., Keskin S., Darendeliler E., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

12. Coagulation assays in breast cancer: Correlation of plasma D-dimer with tumor load and invasiveness in breast cancer patients.

KARABULUT S., Kilic L., Ciftci R., Yildiz İ., Sen F., Keskin S., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

13. Effect of increased body mass index on time to tumor progression in metastatic unresectable colorectal cancer patients treated with bevacizumab-based therapy

Yildiz İ., Sen F., Kilic L., Keskin S., Ciftci R., EKENEL M., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

14. Berrak Hücreli Sarkom Bir olgu nedeniyle

GÜRAL Z., OSKEROĞLU S., ERGÜN S., KILIÇ L., AKGÜN Z., YÜCEL S., et al.

20. Ulusal Kanser Kongresi, Türkiye, 19 - 23 Nisan 2013

Kitaplar 1

1. ADJUVANT CHEMOTHERAPY FOR HER2-NEGATIVE EARLY STAGE BREAST CANCER

Ozer L., Aydıner A.

BREAST CANCER - A GUIDE TO CLINICAL PRACTICE , ADNAN AYDINER,ATILLA SORAN,ABDULLAH IGCI, Editör, Springer, London/Berlin , Geneve, ss.357-383, 2019 Sürdürülebilir Kalkınma

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

713

H-İndeks (WoS)

Atıf (Scopus)

745

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler